glp 1 drugs mechanism Mechanisms by which GLP-1 agonists may exert beneficial effects on the What is GLP-1 and Its

Methods A systematic review was conducted following PRISMA 2020 guidelines (PROSPERO: CRD420261305875)

Once a relatively obscure class of drugs prescribed for people with diabetes, GLP-1s have now shown an impressive ability to treat obesity, which affects...

Discover the evidence on GLP-1s and vision loss, who's at risk, warning signs to watch for, and how to protect your eyesight whilst taking these diabetes and weight-loss treatments.

Unfortunately, misinformation about these medications has also taken the Internet by storm

While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives